Ilaria Gritti

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Ilaria Gritti

Oct 5, 2024, 13:35 | Insight

SI kinase to act as a key signaling mediator of a rare fusion oncogene involved in fibrolamellar carcinoma

Kei Sakamoto, Vice Director of Novo Nordisk Foundation, shared a post by Elizabeth McKenna, on…

Sep 30, 2024, 16:38 | Insight

New work on how DNAJB1-PRKACA fusion drives Fibrolamellar Carcinoma

Ilaria Gritti shared a post on X, by Elizabeth McKenna, about a recent paper published…

Jul 15, 2024, 11:28 | Insight

Meng-Ju Wu: IDH1 inhibition activates tumor immunity by inducing dsDNA sensing

Meng-Ju Wu, Instructor at Harvard Medical School and Massachusetts General Hospital, shared on X about…

All: 3 Posts: 1 - 100

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

'

King Charles III Hospitalized Following Side Effects from Cancer Treatment

'

Keith T. Flaherty has been elected as the AACR President-Elect for 2025-2026

'

MARIPOSA trial results presented at ELCC25 - BREAKING from Paris

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023